de KlerkJ.M.H., Van het SchipA.D., ZonnenbergB.A., van DijK A., StokkelM.P., HanS.H., BlijhamG.H., van RijkP.P.: Evaluation of thrombocytopenia in patients treated with rhenium-186-HEDP: guidelines for individual dosage recommendations. J. Nucl. Med., 35: 1423–1428, 1994.
2.
de KlerkJ.M.H., Van het SchipA.D., ZonnenbergB.A., van DijkA., QuirijnenJ.M.S.P., BlijhamG.H., van RijkP.P.: Phase I study of 186-Re-HEDP in patients with bone metastases originating from breast cancer. J. Nucl. Med., 37: 244–249, 1996.
3.
de KlerkJ.M.H., ZonnenbergB.A., Van het SchipA.D., van DijkA., HanS.H., QuirijnenJ.M., BlijhamG.H., van RijkP.P.: Dose escalation study of rhenium-186 hydroxyethylidene diphosphonate in patients with metastatic prostate cancer. Eur. J. Nucl. Med., 21: 1114–1120, 1994.
4.
EisenhutM., BerberichR., KimmingB., OberhausenE.: Iodine-131-labeled diphosphonate for palliative treatment of bone metastases: II. Preliminary clinical results with iodine-131 BDP3. J. Nucl. Med., 27: 1255–1261, 1986.
5.
HoskinP.J.: Radiotherapy in the management of bone metastases. In: Bone metastases: diagnosis and treatment, RubensR.D., FogelmanI., Eds., pp. 171–185, Springer-Verlag, London, 1991.
6.
KutznerJ., DahnertW., SchreyerT., GrimmW., BrodK.H., BeckerM.: Yttrium-90 zur Schmerztherapie von Knochenmetastasen. J. Nucl. Med. Band., XX/Heft 5, 1981.
7.
MaxonH.R., ThoniasS.R., HertzbergV.S., SchroderL.E., EnglaroE.E., SamaratungaR., ScherH.I., MoultonJ.S., DeutschE.A., DeutschK.F., SchneiderH.J., WilliamsC.C., EhrhardtG.J.: Rhenium-186 hydroxyethylidene diphosphonate for the treatment of painful osseous metastases. Semin. Nucl. Med., 22: 33–40, 1992.
8.
RobinsonR.G., PrestonD.F., SpicerJ.A., BaxterK.G.: Radionuclide therapy of intractable bone pain: emphasis on strontium-89. Semin. Nucl. Med., 22: 28–32, 1992.
9.
SamaratungaR.C., ThoniasS.R., HinnefeldJ.D., von KusterL.C., HyamsD.M., MoultonJ.S., SperlingM.I., MaxonH.R.H.: A Monte Carlo simulation model for radiation dose to metastatic skeletal tumor from rhenium-186(Sn)-HEDP. J. Nucl. Med., 36: 336–350, 1995.
10.
SilbersteinE.B.: The treatment of painful osseous metastases with phosphorus-32-labeled phosphates. Semin. Oncol., 20 (suppl. 2): 10–21, 1993.
11.
TurnerJ.H., MartinadaleA.A., SorbyP., HetheringtonE.L., FleayR.F., HoffmanR.F., ClaringboldP.G.: Samarium-153-EDTMP therapy of disseminated skeletal metastases. Eur. J. Nucl. Med., 15: 784–795, 1989.
12.
WilkinsM.F., KeenC.W.: Hemi-body radiotherapy in the management of metastatic carcinoma. Clin. Radiol., 38: 267–268, 1987.
